EDITORIAL
Published on 05 May 2022
Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
doi 10.3389/fphar.2022.898368
- 1,144 views
- Frontiers in Pharmacology
- Predictive Toxicology
- Research Topics
- Toxicity Mechanism and Clinical features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
Toxicity Mechanism and Clinical features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I
10k
Total Downloads
30k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 19 Apr 2022
PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism
doi 10.3389/fphar.2022.835510
- 6,629 views
- 18 citations
ORIGINAL RESEARCH
Published on 01 Apr 2022
Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis
doi 10.3389/fphar.2022.817662
- 2,420 views
- 12 citations
ORIGINAL RESEARCH
Published on 25 Mar 2022
Frequency of Immune Checkpoint Inhibitor-Induced Vasculitides: An Observational Study Using Data From the Japanese Adverse Drug Event Report Database
doi 10.3389/fphar.2022.803706
- 2,855 views
- 8 citations
ORIGINAL RESEARCH
Published on 18 Mar 2022
Efficacy and Adverse Events of PD-1 Inhibitors in Patients With Advanced Urothelial Carcinoma From a Real-World Experience
doi 10.3389/fphar.2022.837499
- 1,957 views
- 3 citations
ORIGINAL RESEARCH
Published on 04 Mar 2022
Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes
doi 10.3389/fphar.2022.836958
- 2,463 views
- 23 citations
ORIGINAL RESEARCH
Published on 08 Feb 2022
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
doi 10.3389/fphar.2021.819985
- 2,124 views
- 14 citations
REVIEW
Published on 12 Nov 2021
Adverse Effects and Toxicity of Immune Checkpoint Inhibitors For Patients With Urothelial Carcinoma
doi 10.3389/fphar.2021.710943
- 2,233 views
- 11 citations
REVIEW
Published on 13 Aug 2021
Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
doi 10.3389/fphar.2021.733890
- 3,548 views
- 14 citations
Published in
Frontiers in Pharmacology
- Predictive Toxicology
Impact
- 30kTopic views
- 18kArticle views
- 10kArticle downloads